中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

27 records (took 0.015 seconds)

    HIGHLY-CONDUCTIVE COPPER EXTRACTANT FORMULATIONS
    3.
    发明申请
    HIGHLY-CONDUCTIVE COPPER EXTRACTANT FORMULATIONS 审中-公开
    高导电铜提取剂配方

    公开(公告)号：WO2008021129A3

    公开(公告)日：2008-07-24

    申请号：PCT/US2007017629

    申请日：2007-08-08

    Applicant: COGNIS IP MAN GMBH ,  MCSWEENEY DANIEL ,  VIRNIG MICHAEL J ,  MCDONNELL FRANK

    Inventor： MCSWEENEY DANIEL ,  VIRNIG MICHAEL J ,  MCDONNELL FRANK

    IPC: C07C251/32 ,  C07C49/00 ,  C07C255/00 ,  C25C1/00

    CPC classification number: H01B1/22 ,  C07C255/13 ,  C07C255/14 ,  C07C255/15 ,  C07C255/37 ,  C07C255/38 ,  C22B3/0017 ,  C22B3/0021 ,  C22B3/0032 ,  C22B15/0063 ,  C22B15/0089 ,  Y02P10/234 ,  Y02P10/236

    Abstract: A method of creating solvent extraction reagent formulations that have high conductivity by combining (a) phenolic oxime extraction reagent(s) or other extraction reagent(s) in the organic phase of a solvent extraction circuit of a metal recovery operation, comprising combining the phenolic oxime extraction reagent(s) or other reagent(s) with one or more ketone, nitrile and/or amide compounds, or mixtures thereof, to create an extraction reagent formulation with a conductivity of at least 4,000 pS/m, measured according to the provisions of BS 5958 Part I, as well as a method of creating an organic phase that has a high conductivity, preferably a conductivity of at least 250 pS/m, comprising adding to that organic phase in an extraction circuit a phenolic oxime extraction reagent formulation with one or more ketoxime. aldoxime, mixtures thereof, or one or more other extraction reagents, and one or more ketone, nitrile, or amide compounds, or mixture thereof, and novel ketone, nitrile and amide compounds.

    Abstract translation: 一种通过在金属回收操作的溶剂萃取回路的有机相中组合（a）酚肟萃取试剂或其它萃取试剂来生成具有高电导率的溶剂萃取试剂制剂的方法， 肟提取试剂或其他试剂与一种或多种酮，腈和/或酰胺化合物或其混合物接触以产生电导率为至少4,000pS / m的提取试剂制剂，所述提取试剂制剂根据 BS 5958第I部分的规定以及制造具有高导电率，优选至少250pS / m的电导率的有机相的方法，包括在萃取回路中向该有机相中加入酚肟萃取试剂制剂 与一个或多个酮肟。 醛肟，其混合物或一种或多种其他提取试剂，以及一种或多种酮，腈或酰胺化合物或其混合物以及新型酮，腈和酰胺化合物。

    OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE
    6.
    发明申请
    OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE 审中-公开

    公开(公告)号：WO2004002420A3

    公开(公告)日：2004-01-08

    申请号：PCT/US2003/020421

    申请日：2003-06-30

    Applicant: NITROMED, INC. ,  GARVEY, David, S. ,  RANATUNGE, Ramani, R. ,  RICHARDSON, Stewart, K.

    Inventor： GARVEY, David, S. ,  RANATUNGE, Ramani, R. ,  RICHARDSON, Stewart, K.

    IPC: C07C251/32

    Abstract: The invention describes novel cyclooxygenase 2(COX-2) selective inhibitors having at least one oxime group or hydrazone group and novel compositions comprising at least one cyclooxigenase 2(COX-2) selective inhibitor having at least one oxime group or hydrazone group, and optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one COX-2 selective inhibitor having at least one oxime group or hydrazone group, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxigenase 2 selective inhibitors of the invention having at least one oxime group or hydrazone group can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxigenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

Patent Agency Ranking